In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Helping Those Who Serve Act''.

SEC. 2. FINDINGS.

Congress finds the following:
(1) Increasing numbers of members of the Armed Forces
serving in Afghanistan and Iraq are suffering from the
significant injuries of the current conflict: post traumatic
stress disorder and traumatic brain injury (hereafter in this
Act referred to as ''PTSD'' and ''TBI'', respectively) .
(2) A recent report by the RAND Corporation estimated that
of the 1.64 million individuals who have been deployed to
Afghanistan and Iraq, approximately 300,000 individuals
currently suffer from PTSD or major depression and that 320,000
report having a probable TBI during deployment.
(3) The need for mental health services is likely to
increase because deployment lengths have increased in the last
year, the number of troops who have served in multiple
deployments is increasing, and the breaks between deployments
have been infrequent.
(4) Several experts have noted the difficulties faced by
members of the Armed Forces in getting screened, diagnosed, and
treated for PTSD and TBI. The RAND report found that, of those
who met diagnostic criteria for PTSD or major depression, only
53 percent had seen a physician or mental health provider to
seek help for a mental health problem in the past 12 months.
(5) Stigma remains a critical barrier to members of the
Armed Forces who may be in need of psychological care,
especially fears that seeking mental health care will lower the
confidence of others in their abilities, threaten career
advancement and security clearances, and possibly cause removal
from their unit.
(6) Stigma may be greatest among those individuals with the
greatest need for mental health services.
(7) To combat stigma, the Mental Health Task Force of the
Department of Defense and others have noted the need for the
Department to reexamine its policies, including those policies
related to command notification or self-disclosure of
psychological health issues that contribute to fears that
seeking mental health care will negatively affect career
opportunities or advancement.
(8) The Mental Health Task Force stated that this
''widespread perception that seeking psychological health
services is costly to an individual's career . . . must be
challenged through thoughtful refinements in command
notification policies, including redefining the balance between
the need to encourage those in need to seek help and the need
for commanders to know in order to maintain force readiness''.
(9) Congress recognizes that much change is under way to
implement numerous recommendations to address concerns that
soldiers in need of mental health services for PTSD and other
conditions are not receiving, including efforts led by the
Department of Defense and the Department of Veterans Affairs.
(10) However, without addressing stigma at all levels,
including structurally, these laudable efforts may not
accomplish their goals.
(11) In its July 2007 report, the Mental Health Task Force
called for ending overly conservative policies that have the
unintentional consequence of fueling erroneous beliefs that
seeking psychological health care invariably results in
permanent damage to one's military career. For example, the
Task Force called for allowing, in the case of alcohol use by a
member of the Armed Forces, for the member to receive
appropriate and non-prejudicial education and preventive
services, without a requirement for command notification, when,
in a clinician's judgment, the alcohol use does not warrant a
diagnosis of substance abuse or dependency or does not require
entry into a formal treatment program.
(12) In May, responding to some of these concerns,
Secretary of Defense Robert Gates reportedly approved a change
in the Department's security clearance process to help remove
the stigma associated with seeking mental health care. Under
the change, members of the Armed Forces and employees of the
Department of Defense who have received mental health care will
no longer have to acknowledge that when they fill out standard
security clearance forms, unless the treatment was court-
ordered or involved violence.
(13) Congress encourages the Department to explore further
changes to notification and other policies to further reduce
stigma among members of the Armed Forces, especially as it
relates to career opportunities.

SEC. 3. MENTAL HEALTH SERVICES ACCESS DEMONSTRATION PROJECT.

(a) Demonstration Project Required.--The Secretary of Defense shall
conduct a demonstration project designed to develop and test options
for the following:
(1) Increasing access of members of the Armed Forces
returning from deployment abroad, and family members of such
members, to accessible, safe, and confidential mental health
counseling.
(2) Reducing stigma and perceived career repercussions
associated with such members seeking such services.
(3) Making high quality mental health services more user
friendly and accessible for members of the Armed Forces and
their family members, including making services available
outside standard working hours.
(b) Purpose.--The purpose of the demonstration project is to
provide high-quality treatment, using (to the extent practicable)
evidence-based treatment, for a broad range of mental health
conditions, including post-traumatic stress disorder and depression,
with the goal of early intervention to promote effective coping and
resilience.
(c) Duration of Project.--The demonstration project authorized by
this section shall be implemented for a period of three years beginning
not later than one year after the date of the enactment of this Act.

SEC. 4. SPECIAL WORKING GROUP ON CONFIDENTIALITY.

(a) Establishment.--The Secretary of Defense, acting through the
Assistant Secretary of Defense for Health Affairs, shall establish a
Special Working Group, which shall be composed of mental health
professionals from each of the Armed Forces, officials from the Surgeon
General Offices at each Armed Force, members of the Armed Forces who
have been deployed in support of Operation Enduring Freedom or
Operation Iraqi Freedom, and other members as determined appropriated
by the Assistant Secretary.
(b) Appointment.--The Secretary shall make every effort to appoint
members of the working group not later than 60 days after the date of
the enactment of this Act.
(c) Purpose.--The Special Working Group shall develop guidelines
and make recommendations about regulations to ensure that
confidentiality is protected to the maximum extent possible for members
of the Armed Forces participating in the demonstration project.
(d) Specific Duties.--In addition to such other duties as the
Secretary may assign to the Working Group, the duties of the Working
Group shall include the following:
(1) Review of requirements for documentation of health care
visits.--The review of current policies, questionnaires, and
other relevant documents that require official documentation of
health care visits by a member of the Armed Forces seeking
mental health services, including when access to such services
must be documented in the personnel record of a member.
(2) Criteria for changes to command notification.--The
development of guidelines and criteria for the demonstration
project to address any needed changes to military command
notification requirements to ensure that a visit to an off-base
treatment site by a member of the Armed Forces for mental
health services is not recorded on any military medical or
other record of the member, except in accordance with
guidelines developed under paragraph (3).
(3) Guidelines for breach of confidentiality.--The
development of guidelines for the demonstration project to
address the circumstances under which the confidentiality
protections afforded to a member of the Armed Forces
participating in the demonstration project may be breached and
notification to military commanders and documentation in
personnel records may be made. Such guidelines shall provide,
in general, that confidentiality may be broken only if a mental
health professional determines that the member is a threat to
the member or to another person.
(4) Criteria to limit access to treatment records.--The
development of criteria for the demonstration project for
limiting access to the treatment records of members of the
Armed Forces treated at the demonstration locations, including
when to allow, if appropriate, appropriate access and
notification to military commanders consistent with guidelines
developed under paragraph (3).
(5) Criteria for fitness for duty.--The development of
criteria for determining fitness for duty and deployment for a
member of the Armed Forces that does not depend solely on the
number of visits to mental health providers by the member.
(6) Guidelines for payment.--The development of guidelines
for ensuring that demonstration sites under the demonstration
project receive payment from the Department of Defense for
treating members of the Armed Forces notwithstanding any
requirements of the Department that prohibit such payments
without certain commander notification or personnel
documentation requirements.
(7) Changes related to disclosure of services received
under project.--The provision of changes as necessary to ensure
that those receiving care at demonstration locations are not
required to reveal any services they receive at these locations
on any military form or questionnaire, except to comply with
any guidelines developed under paragraph (3).
(8) Standards to assess effectiveness of project.--The
development of evaluation standards and criteria to use to
assess the effectiveness of the demonstration project in
increasing access to care, decreasing stigma, and improving
high quality mental health care provided to members of the
Armed Forces. As appropriate, the evaluation should be
structured to include both pre- and post-demonstration
assessments of changes in--
(A) access and utilization of care;
(B) costs of care;
(C) outcomes of care;
(D) member satisfaction with access to and quality
of care; and
(E) impact on the ability of military commanders to
determine member fitness for duty and deployability.
(e) Submission of Plan and Deadline.--
(1) Plan.--The Special Working Group shall submit to the
Secretary of Defense a plan with details on the implementation
and evaluation of the demonstration project. After approval of
the plan by the Secretary, the Special Working Group shall
submit to Congress the plan.
(2) Deadline.--All duties of the Special Working group,
including submission of the plan under paragraph (1), shall be
completed before selection of any site of the demonstration
project under section 3 but in no case shall the date of
completion of such duties be later than one year after the date
of the enactment of this Act.
(f) Application of Guidelines and Recommendations.--The guidelines
and other recommendations, including changes and standards, developed
by the Special Working Group under this section shall be applicable
only to the demonstration project unless the Secretary of Defense
determines otherwise.

SEC. 5. ADVISORY GROUP FOR OVERSIGHT OF DEMONSTRATION PROGRAM.

(a) Establishment.--The Secretary of Defense shall establish an
advisory group of qualified individuals to oversee implementation of
the demonstration project.
(b) Duties.--The advisory group shall--
(1) ensure that the demonstration project adheres to the
guidelines developed by the Special Working Group under section
4;
(2) ensure that plans for implementing the demonstration at
selected sites are developed and include--
(A) outreach strategies to ensure that participants
in the project are informed about the availability of
the programs being provided under the project; and
(B) a plan for training and certifying mental
health providers as well as the development of
strategies and settings, including settings that are
not located at military treatment facilities, where
care can be offered;
(3) ensure that the demonstration project has detailed
evaluation plans, using the criteria and standards developed by
the Special Working Group; and
(4) ensure that independent evaluations of the
demonstration project are conducted in accordance with the
guidelines developed by the Special Working Group, and that the
results of those evaluations are provided to the Secretary of
Defense.

SEC. 6. REPORTS ON DEMONSTRATION PROJECT.

(a) Reports Required.--
(1) In general.--The Secretary of Defense shall submit to
the Committees on Armed Services of the Senate and the House of
Representatives two reports on the demonstration project.
(2) First report.--The first report shall examine and
assess the plan developed by the Special Working Group under
section 4(e)(1) for implementation and evaluation of the
demonstration project.
(3) Second report.--The second report shall include the
following:
(A) The results of the demonstration project,
evaluated in accordance with the guidelines and other
criteria, changes, and standards developed by the
Special Working Group.
(B) Recommendations on whether any of the policy
changes tested in the demonstration project should be
adopted throughout the Department of Defense.
(C) A plan to ensure that each member of the Armed
Forces participating in the demonstration project
continues to have access to mental health services and
providers after the conclusion of the demonstration
project.
(b) Deadlines.--The first report under this section shall be
submitted not later than one year after the date the demonstration
project begins to be implemented. The second report shall be submitted
at the completion of the demonstration project.

SEC. 7. STUDY AND REPORT ON RETENTION OF MILITARY MENTAL HEALTH
PROFESSIONALS.

(a) Study.--The Secretary of Defense, in consultation with the
Surgeon General of each branch of the Armed Forces, shall conduct a
study to determine the reasons for attrition among military mental
health professionals and to make recommendations to increase
recruitment and retention of military mental health professionals, such
as through scholarships, loan forgiveness, or updates in current
recruiting bonuses.
(b) Report.--Not later than six months after the date of the
enactment of this Act, the Secretary of Defense shall submit to
Congress a report on the study conducted and recommendations made under
subsection (a), including--
(1) the estimated cost of implementing each such
recommendation;
(2) with respect to each branch of the Armed Forces, an
estimate of the existing number of military mental health
professionals and the estimated number of such professionals
required to meet demand, including for future years, for mental
health services; and
(3) any recommendations for legislative changes necessary
to implement the recommendations made under such study.
(c) Military Mental Health Professional Defined.--For purposes of
this section, the term ''military mental health professional'' means a
mental health professional who provides mental health services to
members of the Armed Forces, whether such professional is a member of
the Armed Forces, an employee of the Department of Defense, or a
contractor of the Department of Defense.
Example Output: Helping Those Who Serve Act - Directs the Secretary of Defense to conduct a demonstration project (project) designed to: (1) increase access of members of the Armed Forces (members) returning from deployment abroad, and their families, to accessible, safe, and confidential mental health counseling; (2) reduce the stigma and career repercussions associated with seeking such services; and (3) make high-quality mental health services more user-friendly to such members and their families.

Requires the Secretary to: (1) establish a Special Working Group to develop guidelines and recommendations to ensure the protection of confidentiality for members participating in the project; (2) establish an advisory group to oversee project implementation; (3) submit project reports to the congressional defense committees; and (4) conduct a study of reasons for attrition among military mental health professionals, and make recommendations to increase the recruitment and retention of such individuals.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Keeping Families Home Act of 2014''.

SEC. 2. DEED-FOR-LEASE PROGRAM.

(a) Establishment.--
(1) In general.--Each servicer shall establish a deed-for-
lease program (hereinafter referred to as the ''Program''),
which shall permit an eligible mortgagor to--
(A) enter into a deed in lieu of foreclosure
agreement;
(B) continue to occupy and lease the property that
is the subject of such agreement for a 1-year period
that begins on the date of such agreement; and
(C) have a right of first refusal to purchase such
property after the end of the 1-year lease period, if
the owner of the property intends to sell the property
at that time.
(2) Exception for small servicers.--The Program requirement
under paragraph (1) shall not apply to a small servicer, as
such term is defined by the Secretary of Housing and Urban
Development.
(b) Notice Requirement.--Servicers shall provide each eligible
mortgagor with information about the Program and how to apply to
participate in the Program.
(c) Lease Terms.--A lease entered into by an eligible mortgagor
under the Program shall--
(1) carry a monthly rent amount equal to the fair market
rent for such property, as determined by an independent private
appraiser hired by and paid by the servicer; and
(2) contain all typical lease provisions for similar rental
property.
(d) Application Process.--
(1) In general.--An eligible mortgagor may apply for the
Program at any time.
(2) Effect of foreclosure sale.--If there is a foreclosure
sale pending with respect to the property--
(A) the eligible mortgagor may only apply for the
Program before the date that is 7 days before the date
of such foreclosure sale; and
(B) once the eligible mortgagor applies for the
Program, the foreclosure sale shall be halted until
after the eligible mortgagor's Program application has
been evaluated.
(3) Contents of application.--
(A) In general.--In applying for the Program, an
eligible mortgagor shall provide the servicer with
proof of the following information:
(i) The eligible mortgagor is subject to a
financial hardship that makes the eligible
mortgagor unable to continue making timely
payments on the eligible mortgage loan.
(ii) The eligible mortgagor is eligible to
pay the monthly rent amount described under
subsection (c)(1) and such amount is no more
than 31 percent of the eligible mortgagor's
monthly income.
(iii) The eligible mortgagor currently
lives in the property and intends to continue
doing so during the 1-year lease term.
(B) Ability to pay higher percentage of income in
rent.--Notwithstanding subparagraph (A)(ii), if an
eligible mortgagor believes they are able pay the
monthly rent amount despite such amount exceeding 31
percent of the eligible mortgagor's monthly income, the
eligible mortgagor may request that the Department of
Housing and Urban Development review their information,
along with any contributing factors the eligible
mortgagor may have (such as a low debt burden) and, if
the Department notifies the eligible mortgagor that the
Department agrees that the eligible mortgagor is able
to pay a monthly rent amount that is equal to a
percentage of their monthly income that is higher than
31 percent, such higher percentage shall be used for
purposes of subparagraph (A)(ii).
(4) Effect of junior liens.--If an eligible mortgagor
applies for a Program with respect to a single family property
subject to a junior lien--
(A) if the servicer of the Program is also the
holder of the junior lien, the servicer shall release
the junior lien and, subject to the other requirements
of this section, the eligible mortgagor shall be
eligible to participate in the Program; and
(B) if the servicer of the Program is not the
holder of the junior lien, the servicer shall contact
such junior lien holder and request that the holder
release the lien, and--
(i) if the holder releases the lien, then,
subject to the other requirements of this
section, the eligible mortgagor shall be
eligible to participate in the Program; and
(ii) if the holder does not release the
lien, then the eligible mortgagor shall not be
eligible to participate in the Program.
(e) Evaluation and Notification.--
(1) Deadline for evaluation.--The servicer shall evaluate
the eligible mortgagor's application within 30 days of
receiving such application and shall accept an eligible
mortgagor into the Program if the eligible mortgagor has
provided the proof described under subsection (d)(3)(A).
(2) Notification.--Promptly after making a determination
under paragraph (1), the servicer shall notify the eligible
mortgagor of such determination in writing and, if the servicer
determines that the eligible mortgagor may not be accepted into
the Program, the servicer shall specifically explain in writing
why the eligible mortgage was not accepted.
(f) Subsequent Owners Follow Program Requirements.--Any subsequent
owner of the property being leased pursuant to the Program shall--
(1) maintain the Program and abide by the terms of the
Program to the same extent as the servicer of the eligible
mortgage; and
(2) certify to the Department of Housing and Urban
Development, before finalizing any purchase of the property,
that they will abide by the terms of the Program.
(g) Rulemaking; Compliance Evaluation.--The Department of Housing
and Urban Development shall--
(1) issue such regulations as may be necessary to carry out
this section;
(2) evaluate the compliance by servicers and owners with
the requirements of this section; and
(3) enforce the requirements of this section.
(h) Definitions.--For purposes of this section:
(1) Eligible mortgagor.--The term ''eligible mortgagor''
means a mortgagor under an eligible mortgage.
(2) Eligible mortgage.--The term ''eligible mortgage''
means a first or subordinate mortgage on a property that--
(A) is a single family property; and
(B) is currently being used as the principal
residence of the eligible mortgagor.
(3) Single family property.--The term ''single family
property'' means--
(A) a structure consisting of 1 to 4 dwelling
units;
(B) a dwelling unit in a multi-unit condominium
property together with an undivided interest in the
common areas and facilities serving the property;
(C) a dwelling unit in a multi-unit project for
which purchase of stock or a membership interest
entitles the purchaser to permanent occupancy of that
unit; or
(D) a manufactured housing unit.
Example Output: Keeping Families Home Act of 2014 - Directs each mortgage servicer to establish a deed-for-lease program which shall permit an eligible mortgagor to: enter into a deed in lieu of foreclosure agreement; continue to occupy and lease the property that is the subject of the agreement for one year; and have a right of first refusal to purchase such property after the end of the one-year lease period, if the owner intends to sell the property at that time. Exempts small servicers from such requirement. Requires a lease to carry a monthly rent amount equal to the fair market rent for the property, as determined by an independent private appraiser hired by and paid by the servicer.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Preservation of Antibiotics for
Human Treatment Act of 2002''.

SEC. 2. FINDINGS.

The Congress finds as follows:
(1) Several antibiotics and classes of antibiotics either
are used in or are related to antibiotics used in humans to
treat infectious diseases and are also routinely administered
to healthy agricultural animals, generally via feed or water,
in order to promote the animals' growth or to prevent disease.
Such uses do not require a veterinarian's prescription.
(2) Mounting scientific evidence shows that this
nontherapeutic use of antibiotics in agricultural animals can
lead to development of antibiotic-resistant bacteria that can
be transferred to people, making it harder to treat certain
infections.
(3) In 1997 and in 2000, the World Health Organization
recommended that antibiotics used to treat humans should not
also be used to promote animal growth, although such
antibiotics could still be used to treat ill animals. Most
developed countries in the world, with the exception of the
United States and Canada, restrict the use of antimicrobials in
animal production systems for growth promotion.
(4) In July 1998, the National Academy of Sciences, in a
report prepared at the request of the United States Department
of Agriculture and the Food and Drug Administration, concluded
''there is a link between the use of antibiotics in food
animals, the development of bacterial resistance to these
drugs, and human disease''.
(5) In July 1999, the European Union banned the use for
animal growth promotion of remaining human-use antibiotics
still in use to promote animal growth. Prior to that action,
individual European countries, including the United Kingdom,
Denmark, Finland, and Sweden, had banned the use in animal feed
of specific antibiotics.
(6) In October 2000, the Food and Drug Administration
issued a notice announcing its intention to withdraw approvals
for use of fluoroquinolone antibiotics in poultry, in light of
the fact that increased resistance to fluoroquinolones in
certain bacteria followed approval of those antibiotics for
such use in the mid-1990s. The Food and Drug Administration
concluded that ''the use of fluoroquinolones in poultry is a
significant cause of fluoroquinolone resistant infections in
humans.'' One manufacturer of such drugs is contesting FDA's
proposed withdrawal and continues to market its product.
Previous proceedings by FDA to withdraw approval of animal
drugs have taken substantial amounts of time following
initiation of formal action by FDA, including 6 years in one
instance and 20 in another.
(7) In June 2001, the American Medical Association adopted
a resolution opposing nontherapeutic use of antimicrobials in
animal agriculture. Medical professional organizations that
have taken a similar position include the American College of
Preventive Medicine, the American Public Health Association,
and the Council of State and Territorial Epidemiologists.
(8) In October 2001, the New England Journal of Medicine
published a guest editorial titled ''Antimicrobials in Animal
Feed--Time to Stop''. The editorial urged a ban on
nontherapeutic use in animals of medically important
antibiotics.
(9) The National Academy of Sciences has found that
eliminating the use of antibiotics as feed additives would cost
each American consumer not more than $5 to $10 per year.
(10) In January 2001, a Federal interagency task force on
antibiotic resistance concluded that ''drug-resistant pathogens
are a growing menace to all people, regardless of age, gender,
or socioeconomic background. If we do not act to address the
problem . . . [d]rug choices for the treatment of common infections
will become increasingly limited and expensive--and, in some cases,
nonexistent.''.
(11) Scientific studies published in major peer-reviewed
research journals have shown that resistance traits can be
transferred among unrelated species of bacteria, including from
nonpathogens to pathogens.
(12) Development of resistance to antibiotics could
significantly impair the ability of the United States to
respond effectively to a bioterrorist attack and is likely to
increase the casualties that result from such an attack.

SEC. 3. PRESERVING THE EFFECTIVENESS OF ANTIBIOTICS SUCH AS CIPRO.

(a) Prohibiting the Use of Drugs Related to Cipro in Poultry.--
Section 512(a)(2) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 360b(a)(2)) is amended--
(1) in subparagraph (B), by striking ''and'' at the end;
(2) in subparagraph (C), by striking the period and
inserting ''; and''; and
(3) by adding at the end the following:
''(D) such drug is not a member of the fluoroquinolone
class of antimicrobial drugs, or if such drug is a member of
the fluoroquinolone class of antimicrobial drugs, the Secretary
shall have found, based on information submitted to the
Secretary by the sponsor of such drug, that there exists a
reasonable certainty of no harm to human health due to the
development of antimicrobial resistance that is attributable in
whole or in part to the use in animal feed of such drug.
''Nothing in subparagraph (D) shall be construed to affect an approval
under this subsection for a drug of the fluoroquinolone class of
antimicrobial drugs that is used in or for cattle.''.
(b) Definition.--Section 201(w) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321(w)) is amended--
(1) by striking ''(w) The term'' and inserting ''(w)(1) The
term''; and
(2) by adding at the end the following:
''(2) With respect to subparagraph (D) of section 512(a)(2) (and in
provisions of this Act that refer to such subparagraph), the term
'animal feed' shall include an article that is a fluid administered to
animals other than man. Such term does not include fluids administered
via hypodermic injection.''.

SEC. 4. REQUIRING PROOF OF SAFETY OF ANTIMICROBIAL NEW ANIMAL DRUGS.

(a) Nontherapeutic Use; Applications Pending on or Submitted After
Enactment.--Section 512(d)(1) of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 360b(d)(1)) is amended--
(1) in subparagraph (H), by striking ''or'' at the end;
(2) by redesignating subparagraph (I) as subparagraph (J);
(3) by inserting after subparagraph (H) the following
subparagraph:
''(I) with respect to a critical antimicrobial drug or a
drug of the same chemical class as a critical antimicrobial
drug, the applicant has failed to demonstrate that there is a
reasonable certainty of no harm to human health due to the
development of antimicrobial resistance that is attributable,
in whole or in part, to the nontherapeutic use of such drug;
or''; and
(4) in the matter after and below subparagraph (J) (as
redesignated by paragraph (2)), by striking ''(A) through (I)''
and inserting ''(A) through (J)''.
(b) Phased Elimination of Nontherapeutic Use in Animals of
Antibiotics Important for Human Health.--Section 512 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 360b) is amended by adding at
the end the following:
''(q) With respect to the nontherapeutic use in an animal of--
''(1) a drug that is a critical antimicrobial drug; or
''(2) a drug that is of the same chemical class as a
critical antimicrobial drug;
for which, as of the day before the date of enactment of this
subsection, there was in effect an approval of an application filed
pursuant to subsection (b), the Secretary shall withdraw such approval
on the date that is 2 years after the date of enactment of this
subsection unless the Secretary, based on information submitted to the
Secretary by the sponsor of such drug, has determined prior to the date
that is 2 years after such date of enactment that there is a reasonable
certainty of no harm to human health due to the development of
antimicrobial resistance that is attributable in whole or in part to
the nontherapeutic use of such drug.
''(r)(1) If the Secretary grants an exemption under section 505(i)
or under section 351 of the Public Health Service Act (42 U.S.C. 262)
to a drug that is an antibiotic drug, the Secretary shall rescind each
approval of a nontherapeutic use in an animal of such drug or of a drug
in the same chemical class as such drug upon the expiration of the 2-
year period beginning on the date on which the Secretary grants the
exemption, except as provided in paragraph (3).
''(2) If an application for an antibiotic drug is submitted to the
Secretary under section 505(b) or under section 351 of the Public
Health Service Act (42 U.S.C. 262), the Secretary shall rescind each
approval of a nontherapeutic use in an animal of such drug or a drug in
the same chemical class as such drug upon the expiration of the 2-year
period beginning on the date on which the application is submitted to
the Secretary, except as provided in paragraph (3).
''(3) Paragraph (1) or (2), as the case may be, applies unless,
before the date on which approval would be rescinded under such
paragraph, the Secretary determines that the holder of the approved
application has demonstrated that there is a reasonable certainty of no
harm to human health due to the development of antimicrobial resistance
that is attributable, in whole or in part, to the nontherapeutic use in
an animal of such drug.''.
(c) Definitions.--Section 512 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360b), as amended by subsection (b), is further
amended by adding at the end the following:
''(s) For purposes of this section, the term 'nontherapeutic use',
with respect to a critical antimicrobial drug, means any use of such
drug in an animal in the absence of disease in such animal, including
use for growth promotion, feed efficiency, or routine disease
prevention.
''(t) For purposes of this section, the term 'critical
antimicrobial drug' means any drug that is--
''(1) intended for use in animals other than humans that
are--
''(A) intended for use as, or to generate, food for
humans; or
''(B) intended to breed or otherwise produce
animals described in subparagraph (A); and
''(2)(A) composed wholly or partly of any kind of
penicillin, tetracycline, bacitracin, macrolide, lincomycin,
streptogramin, aminoglycoside, sulfonamide; or
''(B) any other drug or derivative thereof that is used in
humans or intended for use in humans to inhibit or destroy
micro-organisms.''.

SEC. 5. ASSISTANCE TO DEFRAY FARMERS' EXPENSES IN PHASING OUT
NONTHERAPEUTIC USE OF MEDICALLY IMPORTANT ANTIBIOTICS;
PREFERENCE FOR FAMILY FARMS.

(a) In General.--The Secretary of Agriculture may make payments to
producers of livestock or poultry who the Secretary determines are
substantially reducing, or have substantially reduced, the
nontherapeutic use of critical antimicrobial drugs in livestock or
poultry in order to defray the costs of such reduction.
(b) Definition.--In this section the terms ''critical antimicrobial
drug'' and ''nontherapeutic use'' have the meanings given such terms in
section 512(s) of the Federal Food, Drug, and Cosmetic Act (as amended
by this Act).
(c) Priority for Family Farmers.--In awarding payments under
subsection (a), the Secretary of Agriculture shall give priority to
family-owned and family-operated farms or ranches.
(d) Authorization of Appropriations.--There is authorized to be
appropriated such sums as may be necessary to carry out this section
for fiscal year 2003 and for each subsequent fiscal year.
Example Output:
Preservation of Antibiotics for Human Treatment Act of 2002 - Amends the Federal Food, Drug, and Cosmetic Act to deem unsafe animal feed containing a new animal drug which is a member of the fluoroquinolone class of antimicrobial drugs, unless the Secretary of Health and Human Services receives information from the drug's sponsor that there exists a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the use of such drug in animal feed.Requires the Secretary to withdraw or rescind approval of previously approved drugs that are either critical antimicrobial drugs or in the same chemical class as critical antimicrobial drugs, unless the Secretary receives information from the drug's sponsor that there exists a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the use of such drug in animal feed.Authorizes the Secretary of Agriculture to make payments to producers of livestock or poultry who have reduced or are substantially reducing the nontherapeutic use of critical antimicrobial drugs.